9 METERS BIOPHARMA INC's ticker is NMTR and the CUSIP is 654405109. A total of 101 filers reported holding 9 METERS BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $10,000 | +11.1% | 48,108 | +34.0% | 0.00% | – |
Q2 2022 | $9,000 | -93.1% | 35,900 | -83.5% | 0.00% | – |
Q1 2022 | $130,000 | -56.8% | 217,708 | -29.2% | 0.00% | – |
Q4 2021 | $301,000 | -57.0% | 307,666 | -42.8% | 0.00% | – |
Q3 2021 | $700,000 | +120.1% | 537,798 | +85.8% | 0.00% | – |
Q2 2021 | $318,000 | -27.6% | 289,516 | -22.9% | 0.00% | – |
Q1 2021 | $439,000 | +186.9% | 375,565 | +111.5% | 0.00% | – |
Q4 2020 | $153,000 | +705.3% | 177,600 | +678.9% | 0.00% | – |
Q3 2020 | $19,000 | +137.5% | 22,800 | +61.7% | 0.00% | – |
Q2 2020 | $8,000 | – | 14,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 2,750,000 | $3,575,000 | 1.04% |
ODonnell Financial Services, LLC | 840,727 | $1,093,000 | 0.52% |
Orbimed Advisors | 8,565,974 | $11,136,000 | 0.12% |
Paradigm, Strategies in Wealth Management, LLC | 30,800 | $40,000 | 0.04% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 15,000,000 | $19,500,000 | 0.04% |
Ascent Wealth Partners, LLC | 85,224 | $111,000 | 0.02% |
CHARTWELL INVESTMENT PARTNERS, LLC | 475,839 | $619,000 | 0.02% |
Prentice Wealth Management LLC | 29,000 | $38,000 | 0.02% |
Valeo Financial Advisors, LLC | 198,148 | $258,000 | 0.02% |
Almanack Investment Partners, LLC. | 40,850 | $53,000 | 0.01% |